{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:07:41Z","timestamp":1790438861503,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005240","name":"Changjiang Scholar Program of Chinese Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005240","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bbadis.2019.165551","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T19:38:33Z","timestamp":1567712313000},"page":"165551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats"],"prefix":"10.1016","volume":"1865","author":[{"given":"Yun-Long","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Xin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.165551_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11906-017-0777-3","article-title":"Antihypertensive therapies and left ventricular hypertrophy","volume":"19","author":"Soliman","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbadis.2019.165551_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1573403X14666180111145207","article-title":"Oxidative stress and cardiac remodeling: an updated edge","volume":"14","author":"Rababa'h","year":"2018","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.bbadis.2019.165551_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yjmcc.2014.12.007","article-title":"Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP","volume":"79","author":"Li","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cvr\/cvt258","article-title":"Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation","volume":"101","author":"Wang","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2019.165551_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000489757","article-title":"Cardiac ablation of SOCS3 aggravates DOCA-salt-induced hypertrophic remodeling by activation of Gp130-dependent signaling in mice","volume":"47","author":"Liu","year":"2018","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10.1016\/j.bbadis.2019.165551_bb0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11655-017-2818-9","article-title":"Evodiamine inhibits angiotensin II-induced rat cardiomyocyte hypertrophy","volume":"24","author":"He","year":"2018","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1016\/j.bbadis.2019.165551_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/10454411950060020101","article-title":"Chemokines, a family of chemotactic cytokines","volume":"6","author":"Graves","year":"1995","journal-title":"Critical Reviews in Oral Biology and Medicine: An Official Publication of the American Association of Oral Biologists"},{"key":"10.1016\/j.bbadis.2019.165551_bb0045","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/01.CIR.0000093192.72099.9A","article-title":"Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection","volume":"108","author":"Tarzami","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.165551_bb0050","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1128\/IAI.00798-10","article-title":"The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis","volume":"78","author":"Ritzman","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165551_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1172\/JCI1195","article-title":"A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice","volume":"101","author":"Boisvert","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2019.165551_bb0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/emmm.201201717","article-title":"Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes","volume":"5","author":"Soehnlein","year":"2013","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.bbadis.2019.165551_bb0065","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2019.165551_bb0070","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.115.020754","article-title":"Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction","volume":"134","author":"Wang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.165551_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1536\/ihj.51.359","article-title":"Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats","volume":"51","author":"Ishimitsu","year":"2010","journal-title":"Int. Heart J."},{"key":"10.1016\/j.bbadis.2019.165551_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jsbmb.2018.01.009","article-title":"Vitamin D attenuates pressure overload-induced cardiac remodeling and dysfunction in mice","volume":"178","author":"Zhang","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93187","article-title":"Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction","volume":"2","author":"Shimizu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2019.165551_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/cvr\/cvr087","article-title":"Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology","volume":"91","author":"Nishijima","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2019.165551_bb0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1159\/000491966","article-title":"Analysis of genes related to angiotensin II-induced arterial injury using a time series microarray","volume":"48","author":"Zhang","year":"2018","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10.1016\/j.bbadis.2019.165551_bb0100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","article-title":"Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload","volume":"20","author":"Chen","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0105","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.787440","article-title":"Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1","volume":"119","author":"Dolinsky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2019.165551_bb0110","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1166\/jnn.2019.16774","article-title":"Gold nanoparticles for targeting the fibrotic heart: a probe indicating vascular permeability","volume":"19","author":"Yang","year":"2019","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/jcbfm.2013.230","article-title":"Ischemia-reperfusion injury induces occludin phosphorylation\/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner","volume":"34","author":"Muthusamy","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.bbadis.2019.165551_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2019.165551_bb0125","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/kei207","article-title":"Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways","volume":"45","author":"Garrood","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbadis.2019.165551_bb0135","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1152\/ajpregu.00738.2001","article-title":"Chemokines and chemokine receptors in leukocyte trafficking","volume":"283","author":"Olson","year":"2002","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.bbadis.2019.165551_bb0140","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.bjp.0707462","article-title":"Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats","volume":"153","author":"Barsante","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.02.016","article-title":"Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?","volume":"246","author":"Veenstra","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/740987","article-title":"CXCR2 in acute lung injury","volume":"2012","author":"Konrad","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbadis.2019.165551_bb0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCRESAHA.116.304918","article-title":"Adventitial CXCL1\/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture","volume":"116","author":"Anzai","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.165551_bb0160","doi-asserted-by":"crossref","first-page":"11791","DOI":"10.1073\/pnas.0402090101","article-title":"Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury","volume":"101","author":"Bertini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165551_bb0165","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/mp500180e","article-title":"Pyrimidine-based compounds modulate CXCR2-mediated signaling and receptor turnover","volume":"11","author":"Ha","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbadis.2019.165551_bb0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1476-5381.2009.00182.x","article-title":"SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor","volume":"158","author":"Bradley","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cei.12488","article-title":"A pilot study on reparixin, a CXCR1\/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery","volume":"180","author":"Opfermann","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2019.165551_bb0180","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db14-0443","article-title":"CXCR1\/2 inhibition blocks and reverses type 1 diabetes in mice","volume":"64","author":"Citro","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2019.165551_bb0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bjp.2008.270","article-title":"Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice","volume":"155","author":"Zarbock","year":"2008","journal-title":"Br. J. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919302741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919302741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:48:23Z","timestamp":1760417303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919302741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0925443919302741"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165551","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165551"}}